Aquestive Therapeutics AQST
NASDAQ AQST
$5.11 -0.10 (-1.92%)
As of: Sep 9, 2026 · 1:49 PM EDT

Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017)

Aquestive Therapeutics (AQST) posted Preferred Dividend Payments of $626000.0 for Q4 2017, little changed on a QoQ basis from $626000.0 in Q3 2017.

Analysis

Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017) Analysis & Trends

Aquestive Therapeutics has reported Preferred Dividend Payments for 1 years, with the latest figure at $626000.0 in Q4 2017.

  • On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $626000.0 in Q4 2017; TTM through Dec 2018 was $626000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $2.5 million, changed N/A from the prior year.
  • Preferred Dividend Payments was $626000.0 for Q4 2017 at Aquestive Therapeutics, roughly flat from $626000.0 in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $626000.0 in Q3 2017, with the low at $615000.0 in Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn -
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn -
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn -
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.23 Bn 44.23 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn -
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn -
10 Aquestive Therapeutics 638.72 Mn 540.23 Mn 9.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 626,000.00
Sep 30, 2017 626,000.00
Jun 30, 2017 615,000.00